Cantech Holding Inc BSSP
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 371.89M
- Market Cap
- $371.89
- Volume/Avg
- 850,000 / 415,359
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company’s product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- http://www.cantechholding.com
Valuation
|
Metric
|
BSSP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BSSP
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −2.35 |
Quick Ratio
No chart available
Profitability
|
Metric
|
BSSP
|
|---|---|
Return on Assets (Normalized) | −2,927.99% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|rz^NNjl | LOCK|t&n%? | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|st$#>J | LOCK|<&r^R | $76B | |||
| Moderna Inc
MRNA
| LOCK|l<Dl@y! | LOCK|Lm | $75B | |||
| argenx SE ADR
ARGX
| LOCK|j>pJX!r | LOCK|YS# | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Lv@db@$ | LOCK|P^ | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<lBxX& | LOCK|?GYJK | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|kY<<^Wv | LOCK|M%#C | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|S?H%@>l | LOCK|&!@ | $24B | |||
| Incyte Corp
INCY
| LOCK|%?@rR< | LOCK|j!N | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|BX&lH> | LOCK|Kz | $15B |
United States